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Abstract
Background Since March 2003, we have used the Cousin
Bioring in our laparoscopic gastroplasty procedures for
morbid obesity. The Bioring belongs to the new generation
of adjustable gastric bands. The aim of this study is to
review our experience with this particular type of band.
Methods Between March 2003 and March 2010, 316
patients had a laparoscopic implantation of the Cousin
Bioring in our department. As many as 169 patients had the
operation at least 5 years ago, of which 161 had a complete
follow-up. Short- and long-term results were prospectively
collected and analysed.
Results There were no intra-operative and only two mild
early post-operative complications. Mortality was zero. The
mean percent of excess weight loss (%EWL) was 56% at
5 years, 55% at 6 years and 56% at 7 years. Of the 169
patients, four had a band removal for intolerance and/or
insufficient weight loss and 11 (6.5%) developed late
complications requiring surgery. We managed to solve all
complications by minimally invasive procedures without
loss of the device. Fifteen of the 169 patients suffered
preoperatively from diabetes mellitus type 2. Ten of these
had a remission after 5 years. The quality-of-life was
assessed 3 years post-operatively for 164 patients and
showed an improvement in 83.5% of them.
Conclusion Laparoscopicimplantation of the Cousin Bioring
is a straightforward and safe operation. Complications occur,
but they are rather benign and easy to remediate. The mean
weightlossisconsideredsuccessful(%EWL>50)andpersists
5 to 7 years after the operation.
Keywords Morbid obesity.Bariatric surgery.
Laparoscopy.Laparoscopic adjustable gastric banding
Introduction
Laparoscopic adjustable gastric banding has been proven a
safe and efficient surgical treatment of morbid obesity [1,
2]. The first laparoscopic implantations of gastric bands
were carried out in Belgium in the early 1990s by Cadière
[3] and Belachew [4] separately.
We were among the first centres both in Europe and
worldwide to perform these procedures shortly after the
market introduction of the first gastric bands in the fall of
1994. Thus, by March 2003, when we started the
implantation of the Cousin Bioring, our department had
implanted more than a thousand other gastric bands.
Description of the Adjustable Gastric Band Bioring
The Bioring is designed for laparoscopic implantation
(Fig. 1). It has a streamlined profile without rigid
protrusions and is made of supple silicon. It can be
introduced into the abdomen either through a 12-mm trocar
or through a 10-mm trocar stab wound. It glides without
resistance through a tight retro gastric tunnel and appears to
place itself in a ready position for closure since it is
circularly pre-shaped. Arrows on the radio-opaque non-
kinking catheter point to the end plug. Using two graspers
and gentle traction, the band can be closed and opened ad
libitum, both at the time of the original operation and
during revisional surgery. Another feature is the very low
pressure inside the band, which is maintained even at high
fill volumes thanks to the “pair of bellows” inflation
system. When the Bioring is being filled, the inflatable
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inner silicon layer is pushed towards the middle of the ring
(Fig. 2), which helps it maintain its natural adhesive
characteristics, thus avoiding gastric wall slipping.
The Bioring is a grey monoblock band, apart from a
green radio-opaque strip, which is stuck to the outside of
the ring. These absorbent colours prevent a bothering flash
effect during laparoscopy. The inflation area is 360°. When
the band is inflated, even at high fill volumes, the pair of
bellows system prevents the formation of sharp triangular
creases at the level of the inflatable silicon. Instead,
rounded-off folds are formed without contact either
between the two inflatable edges or between inflatable
and non-inflatable silicon (Fig. 3). This particular feature
appears to prevent late central leaks by crease-fold fracture.
The catheter of the Bioring is connected by a tapered
connector to a 10.4-mm high low-profile access port with a
large septum (diameter, 16 mm; Fig. 1). This new (since 2009)
access port guarantees a stable position on the fascia and
seems to facilitate puncturing during adjustments. Although
the access port is radio-opaque, in our experience, radioscopy
is rarely needed when adjusting the device. Since 2010, a self-
adhesive access port of the same size is available.
The aim of this study is to review our experience with
this particular type of adjustable gastric band. In this study,
follow-up data of only the patients who had completed at
least 5 years after the operation were analysed.
Materials and Methods
Between March 2003 and March 2010, 316 consecutive
patients benefited from the laparoscopic implantation of a
Cousin Bioring in our department. At the time of writing
this paper, 169 patients had been operated on for 5 to
7 years with a mean of 69 months. In this group, the male-
to-female ratio was 42/127. Body mass index (BMI)
preoperatively ranged between 34 and 59 kg/m² (mean
42.6). Weights ranged between 88 and 190 kg (mean
117 kg) and ages between 16 and 66 years (mean 40 years).
As many as 15 patients suffered from diabetes mellitus type
2 (DM2). Seven patients were insulin-dependent, and eight
were treated solely by oral anti-diabetic agents.
Of the 169 patients, 163 had a primary operation, two
had a band implantation after a failed Mason procedure,
one after a Nissen fundoplication and three had a rebanding
procedure after removal of another type of band (twice for
intra-gastric band erosions and once for leakage at the level
of the inflatable part of the band). The rebanding
procedures after band erosions were carried out 4 months
after the band removal. In the case of leakage, band
replacement was performed in one stage. All 169 patients
were accessed via the pars flaccida route, and stabilising
anterior gastric sutures were systematically placed.
In the first post-operative year, the patients were seen once
a month on average. Later, the number of visits gradually
decreased. If needed, we started adjustments of the band from
the third post-operative week. We did not follow a strict
adjustment algorithm but rather a custom-made adjustment
policy, depending on the weight loss, the patients’ history
(eating pattern, vomiting, etc.) and the individual wishes of
the patients. Generally, the band was left empty at the time of
its implantation. In most of the patients, at the time of the first
adjustment,2to3cm
3 of saline was injected; at the second, 1
to 1.5 cm
3, followed by smaller increments. The mean
Fig. 1 This figure shows the complete Bioring device. The Bioring is
connected by a tapered connector with a “trumpet end” to a low-
profile, large septum access port
Fig. 2 This figure shows a frontal section of the Cousin Bioring before
and after partial inflation. Because of the “pair of bellows” mechanism,
the inner layer of silicon is pushed towards the centre of the band. The
inflatable silicon does not stretch, allowing for the pressure inside the
band to remain very low, even at higher fill volumes
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operative years are shown in Table 1.
The improvement of the quality-of-life (QOL) was
assessed 3 years post-operatively in 164 patients using the
Moorehead–Ardelt QOL questionnaire scoring test 1. This
test evaluates self-esteem, physical, social, work and sexual
well-being [5].
The evolution of one co-morbidity (DM2) was moni-
tored by the use of anti-diabetic agents.
In this group of 169 patients, the follow-up was
completed for 161 of them. We inquired by phone about
the condition of the eight patients lost to follow-up. Five
of them pretended to be satisfied by the treatment but
refused further follow-up in our department because they
had no problems, especially since three of them were
also living abroad. None of them had a complication.
One patient died of unrelated cause but had no problem
with the band. One patient had the band explanted
laparoscopically in another hospital for intolerance and
insufficient weight loss, and another one had the band
elsewhere explanted and converted to a laparoscopic
gastric bypass for the same reasons.
Forthisstudy,short-andlong-termdatawereprospectively
collected, extracted and analysed from the paper charts of the
patients,whichareavailableforallpatientsandweremanaged
exclusively by the corresponding author (EN).
Results
The Operation and the Post-Operative Course
All 169 procedures were completed laparoscopically. There
were no intra-operative complications. Early post-operative
complications were two cases of mild and transient
dysphagia. Mortality was zero. Hospital discharge was on
the first post-operative day for 165 of the 169 patients.
Weight Evolution
The mean weight loss of the 161 patients with a complete
follow-up, expressed as absolute weight loss (kilograms),
BMI loss and %EWL, is shown in Table 2. %EWL was
calculated on weight above BMI 22.5 (ideal weight).
At 5 years, %EWL was <25 for six patients (3.7%), 25–50
for 21 patients (13%), 50–75 for 116 patients (72%), 75–100
for 15 patients (9.3%) and >100 for three patients (1.9%).
Late Complications Requiring Surgery and Reoperations
The reasons for and the number of re-interventions, as well
as their surgical approaches, are listed in Table 3.
Of the 169 patients, four asked for band removal for
intolerance and/or insufficient weight loss, two of them in
our department and two in another hospital. One of the
latter had a one-stage conversion to a gastric bypass.
Another one of these four patients was the one who had a
Nissen fundoplication earlier. While these are not real
complications, they are an obvious failure of the treatment.
Four patients developed late pouch dilatations treated by
laparoscopic repositioning of the Bioring to a higher level.
These operations were completed uneventfully and with
surprising ease. The helpful factors were the suppleness and
streamlined profile of the band, as well as the ease of
opening the Bioring.
Table 1 Mean number of post-operative visitis and adjustments
during the first 5 years
Years of post-operation No. of visits No. of adjustments
1 12.3 6.3
2 5.2 2.9
3 2.8 2.1
4 2.3 1.1
5 1.5 1.1
Fig. 3 This figure shows the
Bioring being inflated by 2 cm
3
(left), 4 cm
3 (middle) and 6 cm
3
(right) of saline. The inflation
area is 360°. The pair of bellows
mechanism prevents the forma-
tion of sharp triangular creases
at the level of the inflatable
silicon. Instead, rounded-off
folds are formed even at high fill
volumes. This feature prevents
the development of late central
leaks by crease-fold fracture
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through the ring. At laparoscopy, the band was opened,
the slipped stomach reduced underneath the band, some
new gastro-gastric sutures were placed and the band was
closed again.
The above-mentioned seven laparoscopic reoperations,
carried out in our department, were uncomplicated, and all
the patients were discharged on the first post-operative day.
Six patients needed a re-intervention for problems at or
close to the access port. In one patient, there was a
disconnection between the port and the catheter of the
Bioring. In this patient, laparoscopy was needed to pick up
the catheter from the abdomen. In two patients, there was a
180° rotation of an older type of port, which made the
system inaccessible. Three more patients had a leak at the
level of the catheter close to the access port. All these six
problems were solved on a day-surgery basis. To date, we
have no record of any infections of the device or any intra-
gastric erosions or central leaks of the bands.
QOL
Three years after the operation, 4% of the 164 patients
tested mentioned a diminished QOL; 12.5% experienced no
change; 24% experienced improvement and 59.5% great
improvement.
Evolution of Diabetes
Of the 15 DM2 patients, 10 benefited from a complete
remission of DM2 (Table 4).
Discussion
Laparoscopic adjustable gastric banding procedure started
more than 15 years ago and is today one of the highest
performed surgical procedures for the treatment of morbid
obesity worldwide [6]. It has meanwhile been proven an
efficient and safe method.
In the beginning, as with any new procedure, there were
numerous problems and complications [1, 2, 7–11]. This
was due to several reasons. First, there was the learning
curve and the lack of appropriate surgical instruments.
Second, in the 1990s, the bands were implanted via the
perigastric route, which caused a significant number of
anterior and posterior gastric wall slippings, as well as some
band erosions [1, 2, 10, 12–14]. In a retrospective study of
973 patients who had a Lap-Band implanted (511 first
patients perigastric and 462 last patients pars flaccida),
Dargent reported a decrease in the number of slippings
within 34 months after the operation from 5.2% (perigas-
tric) to 0.6% (pars flaccida) [10]. In a randomised
prospective study of 202 patients who had a Lap-Band
implanted (101 patients perigastric and 101 patients pars
flaccida), O’Brien reported a 16% prolapse rate after 2 years
in the perigastric group compared to 4% in the pars flaccida
group [12]. Third and last, the first-generation bands were
hard and rigid high-pressure bands with prominent protru-
sions; they were difficult or impossible to reopen, with poor
connections between the access port and the catheter and
fragile silicon at the level of the inflatable part. With
growing experience, adapted surgical instruments and better
optical systems, the ubiquitous use of the pars flaccida
Years of post-operation No. of patients WL (kg) BMIL %EWL
1 161 25.3 9.2 46
2 161 29.7 10.8 54
3 161 31.9 11.6 58
4 161 31.4 11.4 57
5 161 30.8 11.2 56
6 105 30.3 11 55
7 21 30.8 11.2 56
Table 2 Mean weight loss
expressed as absolute weight
loss, BMI loss and %EWL
Mean weight and BMI preoper-
atively are117kgand42.6kg/m²,
respectively
Problem Number of patients Surgical approach
Removal for intolerance 4 Laparoscopy
Pouch dilatations 4 Laparoscopy
Gastric wall slippings 1 Laparoscopy
Erosions 0
Central leaks 0
Infections 0
Port- related problems 6 5 Local+1 laparoscopy
Table 3 Re-interventions
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availability of a new generation of smooth and supple low
pressure bands, overall results have improved remarkably
[1, 2, 10, 12, 13]. At the time of our first Bioring
implantations in 2003, all the above-mentioned require-
ments were met. Consequently, we succeeded to operate
169 consecutive patients without intra-operative and with
only two benign early post-operative complications.
However,somelatecomplicationsdeveloped.Inthisseries
of 169 patients with a follow-up of at least 5 years and a mean
follow-up of 69 months, there were six (3.6%) complications
requiring laparoscopic reoperations (four pouch dilatations,
one gastric wall slipping and one port disconnection) and five
(3%)port-relatedcomplicationswhichwemanagedtotreatby
a strictly subcutaneous approach. Until today, there were no
erosions, central leaks or infections of the Bioring. So far, all
these late problems were swiftly treated without complica-
tionsandwithoutthelossofthedevice.Inaddition,fourofthe
total group of 169 patients (2.4%) had a band removal for
intolerance and/or insufficient weight loss, one of them with
conversion to a gastric bypass. Thus, the overall complication
rate was 11 (6.5%), and the reoperation rate was 15 in 169
patients (8.9%).
Reviewoftheliteratureindicatesthatthislatecomplication
and reoperation rate were low. Weiner reported similar results
in a study of 984 patients (most of them Lap-Bands). Major
complications including slippings, erosions and band replace-
ments occurred in 3.9%, and port problems occurred in 2.2%
of the patients. However, the follow-up period in this series
was somewhat shorter (follow-up 1–99 months; mean
55.5 months) compared to our series, and 24 patients had a
non-complete follow-up [1].
In a series of 1,000 patients (1,111 patients of whom 111
lost to follow-up) who had a Lap-Band implanted,
Chevallier reported a cumulative rate of complications of
19.3%. Abdominal reoperations, including port disconnec-
tions, were required in 11.1% of the patients. In addition,
3.6% of the patients had a port problem that was treated by
a subcutaneous approach. However, the follow-up period in
this series ranged only between 0 and 7 years (5 and 7 years
in our series) and 11% of the patients were lost to follow-up
[13]. In a series of 1,791 patients, after Lap-Band
implantation, Favretti reported a 5.9% major complication
rate (including slippings, erosions, pouch dilatations, band
removals for intolerance and infections) and 11.2% port-
related problems. The follow-up in this series ranged
between 0 and 12 years and about 9% of the patients were
lost to follow-up [15]. In a series of 591 patients after
implantation of a Lap-Band, a Lowate band, a Swedish
band or a Minimizer band, Biagini reported a late
complication rate of 22.3%. Of these complications,
35.5% were band failures, half of them at the level of the
port and half of them at the level of the catheter or the
inflatable part of the device (leaks or failures of the locking
mechanism). Other complications were slippings, erosions,
infections, intolerances and high band positions. The
follow-up in this study ranged between 0 and 10 years
(mean 35 months), and many patients were lost to follow-
up (e.g. in the group of patients >4 years after the initial
operation, 25.5% were lost to follow-up) [2].
In a study of 123 patients after implantation of a
Swedish band, Tolonen reported a complication rate of
24.4%, including leaks, slippings, erosions, infections and
severe reflux symptoms. As many as 30 patients (24.4%)
needed at least one reoperation, 10 of them for a central
leak of the band but only three (2.4%) of them for a
problem at the level of the port. The follow-up period in
this study ranged between 5 and 11 years (mean 86 months)
but 20% of the patients were lost to follow-up at 5 years
and 30% at 8 years [14]. Recently, Mittermair reported in a
study of 785 patients who had a Swedish band implanted
complications (but apart from the classic complications also
including oesophagitis and oesophageal dilatations) in
50.4% of the patients. Fifty patients (6.4%) developed a
central leak of the band. A reoperation was needed in 32% of
the patients. Reoperation rate at the level of the port was
9.17%. The follow-up period in this study ranged between 1
and 10 years (mean 3 years). Many patients in this study were
lost to follow-up (completeness of follow-up 73%) [8].
In a study of 317 patients treated with either a Lap-Band or a
Swedish band,Suterreported33.1%of thepatients with atleast
one late complication (but apart from the classic complications
also including intolerance, severe reflux symptoms and
insufficient weight loss). As many as 133 reoperations were
needed in 94 (29.6%) patients, of which 45 were needed at the
level of the port. The follow-up period in this study ranged
between 27 and 101 months (mean 74 months), and depending
on the number of years after the initial operation, 1.3% to
33.4% of the patients were lost to follow-up (e.g. 11.8% of the
eligible patients 5 years after the initial operation) [7].
In this study, the mean weight loss curve expressed as %
EWL calculated on weight above BMI 22.5, went up
steeply during the first year (%EWL 46) and reached its
summit after 3 years (%EWL 58) then went slightly down
over 2 years (%EWL 56 after 5 years) and then stabilised.
Reported weight losses after gastric banding vary greatly in
recentliterature.Favrettireporteda meanEWLofonly37.3%
and 37.4% 5 and 6 years, respectively, after Lap-Band
Table 4 Evolution of diabetes mellitus type 2 (15 patients)
Preoperatively Five years post-operation
Insulin-dependent 7 2
Oral agents only 8 3
Off medication 0 10
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82.8% 6 years after implantation of several types of gastric
bands [2]. In a systematic review of the literature, O’Brien
reported a mean EWL of 54% and 53% 5 and 6 years after
implantation of Lap-Bands and Swedish bands [16]. Most
other authors reported similar EWL between 45% and 60%
after 5 or 6 years [1, 8, 14], and this was our experience too.
We believe that the major weight loss achieved over the first
year was influenced by our adjustment policy. Especially
during the first post-operative months, we performed frequent
and rather aggressive adjustments. Subsequently, adjustments
were more gentle which helped achieve fine-tuning of the fill
volume at the end of the weight-loss process. Even several
years after the operation, we regularly perform adjustments in
order to obtain a permanent weight loss, also taking into
account the wishes of each individual patient (Table 1). We
also believe this policy has contributed to the fact that only
four of the 169 patients have asked for a band removal for
intolerance and/or insufficient weight loss. As a consequence,
it is not surprising that we have found that 83.5% of patients
experienced a better or a markedly better QOL 3 years after
the operation compared to preoperatively. Myers reported
similar results in a study of 67 patients with a mean follow-up
of 27 months, but by using the Moorehead–Ardelt QOL
questionnaire scoring test 2 [17]. Of the 169 patients, 15
suffered preoperatively from DM2, seven of them being
insulin-dependent. Of these seven patients, four benefitted
from a full remission of DM2 after 5 years, one needed oral
anti-diabetic agents only and two remained insulin-dependent.
Of the eight DM2 patients treated preoperatively by anti-
diabetic agents solely, six benefitted from a full remission after
5 years while two continued their medication (Table 4).
O’Brien recently reported similar results where gastric
banding leads, in adults with mild to severe obesity, to
remission in three out of four patients [18].
In conclusion, the results of this study appear to show that
laparoscopic implantation of the Cousin Bioring for morbid
obesity is a very safe operation. The number of late
complications requiring surgery so far has been low (6.5%)
compared to most other recently published series. We believe
this is partly because we had already an extensive experience
with other gastric bands when we started implantations of
Bioringandpartlybecauseofthespecificcharacteristicsofthe
Bioring itself. Moreover, all complications could be solved
through minimally invasive and safe procedures and without
the loss of the implant. The mean weight loss in this study is
comparable to what has been reported in recent literature and
can be considered as acceptable (%EWL>55) up to 5, 6 and
7years after theoperation.After 5years,134 patients(83.2%)
had an acceptable %EWL>50. Not all the patients with a %
EWL<50after 5years weredisappointed.Inthe vastmajority
of the patients, maximal patient satisfaction was achieved
thanks to the adjustability of the system, allowing for an
individual compromise between good weight loss and
acceptable food restriction.
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